The Key to COVID Screening is Right Under Your Nose
Early pandemic solutions have proven insufficient for screening for COVID. The data is clear, smell testing is more effective at screening COVID than temperature screening and weekly PCR testing, and it’s far more affordable.
Reopen Your Business & Welcome Back Customers
Whether you’re looking to fill empty stadium or airplane seats or reopen your bar, salon, or gym, Symp2Pass Scentry provides a quick and affordable point of entry screening that reduces the risk of COVID by 75% without requiring personal information from your customers or guests.
You Can Afford to Protect Your Employees & Students
Symp2Pass Common Scents program provides end-to-end COVID screening for your business or school, and it’s more effective than PCR testing and 1/20th the cost. Best of all Symp2Pass does not require any personal information.
Schedule a Symp2Pass Demo
Screen 24/7
Symp2Pass allows you to provide COVID symptom screening 24/7.
No personal data
Users' need not worry about privacy concerns. Symp2Pass screens without personal information.
Fast & effective
Symp2Pass tests take less than 20 seconds to complete and provide test results instantly.
Why Target Sense of Smell?
Fast, Effective, and NO Personal Info
How It Works
We have vaccines now, so do we still even need screening?
Yes. We are far from herd immunity or universal vaccination. Many experts believe even with vaccination efforts in full force, the theoretical threshold for vanquishing COVID-19 looks to be out of reach.
No one knows how long a vaccine will remain effective or how it will perform against variants. According to the Centers for Disease Control and Prevention, the current vaccines’ high efficacy doesn’t mean health officials know how much vaccines will reduce coronavirus transmission or how long the vaccine’s protection will last. As the vaccination rate increases, screening shouldn’t drop because more people are vaccinated.
Continued screening is essential to prevent outbreaks and virus hot spots. Screening helps detect and track emerging variants early and could help us finally stay ahead of the virus rather than simply reacting to it, as we have for the past year. “This virus is still circulating; we still need to identify the people who need to stay home and not transmit their effects to others,” Jennifer Nuzzo, doctor of public health and senior scholar at the Johns Hopkins Center for Health Security.